Clinical trial
Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D [Launchpad Lyumjev]
NCT06948760 is registered in ClinicalTrials.gov with Mark D. DeBoer, MD, MSc., MCR as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D [Launchpad Lyumjev]
- Lead sponsor
- Mark D. DeBoer, MD, MSc., MCR
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 23, 2025
- Completion date
- March 10, 2026
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes